"When will the next attack come?" Attack anxiety in people with migraine.
"When will the next attack come?" Attack anxiety in people with migraine.
For people with migraines, the suffering often goes beyond the actual headache. As soon as the pain fades, they start worrying when the next attack is going to hit. This anxiety can have serious consequences. In fact, it can even increase the risk of new attacks and may contribute to other health issues.
Attack anxiety: what exactly is it?
As early as the late 1980s, the American journal Psychosomatic Medicine published an article on this anxiety phenomenon in people with migraines. Researchers at the renowned Johns Hopkins University in Baltimore surveyed 10,000 individuals using a reliable, standardized questionnaire from the National Institute of Mental Health. The survey covered various aspects of participants’ well-being, including the occurrence of anxiety or panic attacks. If anxiety or panic attacks occurred, the researchers also recorded the participants’ headache burden to determine whether there were significant differences compared with people without such symptoms. They found that participants who experienced anxiety and panic attacks reported unusually frequent and especially long-lasting headaches during the study period, including migraine-type headache attacks. Male participants with anxiety and panic attacks reported having a migraine in the week before the survey seven times more often than participants in the “anxiety-free” comparison group. Other scientific studies have found that, conversely, people with migraines are up to four times more likely to develop true panic attacks than individuals without this type of headache.
Anxiety and migraine: a bidirectional relationship
Over the past decades, numerous studies have shown that the relationship between anxiety and migraine is bidirectional. This means that having one of these conditions significantly increases the risk of developing the other. Since the 1990s, researchers have increasingly proposed explanations for this interaction. Different research approaches have considered different causes, including genetic factors, neurotransmitters in the nervous system, hormonal fluctuations, and the hypothalamic-pituitary-adrenal axis (HPA axis). The HPA axis is the name given to a complex regulatory system, mediated primarily by chemical messengers, involving the hypothalamus, pituitary gland, and adrenal cortex. It influences many bodily functions, including the stress response, which plays a key role in migraine. The hypothalamic-pituitary-adrenal axis is therefore also referred to as the stress axis.
For people with migraine, the periods between attacks can be just as distressing as the attacks themselves. In one large clinical study, more than half of participants reported that the fear of the next headache was one of the hardest parts of living with migraine. Constant shifts between phases of anxiety and migraine attacks often result in nearly continuous emotional and psychological stress, creating a breeding ground for numerous accompanying mental health comorbidities.
Migraine rarely comes alone
As research efforts have intensified, it has become increasingly clear that migraine cannot be viewed as an isolated condition. States of psychological stress such as anxiety disorders, panic attacks, sleep problems, and depressive disorders are typical comorbidities (for more, read this article). The risk of these comorbidities is particularly high among patients whose migraines are accompanied by aura.
A newer study from 2025 examines how strongly migraine comorbidities impact all areas of the affected individuals’ lives. They become both objectively and subjectively less able to meet the demands of work or to enjoy their leisure time, and their overall quality of life is significantly reduced.
Sleep disturbances place a particular burden on patients. A Japanese research group examined migraine patients for various forms of sleep problems, including insomnia, sleep apnoea, and the inability to reach deep sleep phases, which are essential for restful sleep. A large share of participants (87%) reported being affected by at least one of these issues. The impact of these sleep problems was reflected in widely used assessment tools such as the MIDAS (see here for more about MIDAS and why it’s important).
All of this shows that for many people, migraine leads to a level of disease burden that goes far beyond what is commonly associated with a headache disorder.
Harmful coping strategies: medication overuse
How do patients respond to these many stressors? A research group at the University of Bologna has shown that the “specific illness phobia” associated with migraine, meaning the constant fear of the next attack, often leads patients to take pain medication preventively in an attempt to ward off future attacks. This can have serious consequences, because medication overuse can itself cause a particularly severe and difficult-to-treat type of headache known as medication-overuse headache (see here for more information). The Italian study identified a direct relationship between the intensity of attack-related anxiety and the extent of medication use, demonstrating that there is a significant need for patient education on appropriate preventive measures.
How to address anxiety
Through many years of research and clinical practice in the complex field of migraine, several non-pharmacological treatment strategies have been developed. These approaches aim to prevent attacks without the use of medication. Independent studies have repeatedly demonstrated the effectiveness of some of these methods, and they have long been used successfully in migraine treatment.
A central focus is stress reduction. Increased stress perception is a potential trigger for migraine attacks. Ongoing stress leads to a generally heightened vulnerability to headache. Significant spikes in stress, whether physical or emotional, can directly trigger attacks.
Effective non-pharmacological methods
Cognitive Behavioural Therapy (CBT) is a specific form of psychotherapy in which negative thoughts and behaviours related to the patient’s migraine condition are identified and challenged. By changing thought and behaviour patterns, patients learn to develop better coping strategies and to shift their perception of pain. Studies show that CBT helps reduce both the frequency and severity of migraine attacks.
Another method is Progressive Muscle Relaxation (PMR) developed by Jacobson. PMR has also proven effective in migraine prevention. Patients consciously focus on tensing and then relaxing different muscle groups. This reduction in overall muscle tension, and therefore in overall bodily tension, can help relieve migraine pain and prevent attacks. Instructions for PMR can be found here or in the app.
By practising these evidence-based methods, people with migraine can regain some sense of control over their condition. Feelings of helplessness and the constant fear of the next attack may lose some of their intensity, which in turn can help reduce the overall burden of the illness.
Published: November 2025
-
Literature
read
Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991 Apr;37(1):11-23. doi: 10.1016/0165-1781(91)90102-u. PMID: 1862159.
Estave PM, Margol C, Beeghly S, Anderson R, Shakir M, Coffield A, Byrnes J, O'Connell N, Seng E, Gardiner P, Wells RE. Mechanisms of mindfulness in patients with migraine: Results of a qualitative study. Headache. 2023 Mar;63(3):390-409. doi: 10.1111/head.14481. Epub 2023 Feb 28. PMID: 36853655; PMCID: PMC10088163.
Fox J, Gaul C, Ohse J, Peperkorn N, Krutzki J, Shiban Y. Psychological transdiagnostic factors and migraine characteristics as predictors of migraine-related disability. J Headache Pain. 2025 Jul 23;26(1):167. doi: 10.1186/s10194-025-02101-4. PMID: 40702422; PMCID: PMC12285010.
Giannini G, Zanigni S, Grimaldi D, Melotti R, Pierangeli G, Cortelli P, Cevoli S. Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study. J Headache Pain. 2013 Jun 10;14(1):49. doi: 10.1186/1129-2377-14-49. PMID: 23759110; PMCID: PMC3686604.
Grazzi L, Andrasik F, D'Amico D, Usai S, Rigamonti A, Leone M, Bussone G. Treatment of chronic daily headache with medication overuse. Neurol Sci. 2003 May;24 Suppl 2:S125-7. doi: 10.1007/s100720300059. PMID: 12811610.
Karimi L, Wijeratne T, Crewther SG, Evans AE, Ebaid D, Khalil H. The Migraine-Anxiety Comorbidity Among Migraineurs: A Systematic Review. Front Neurol. 2021 Jan 18;11:613372. doi: 10.3389/fneur.2020.613372. PMID: 33536997; PMCID: PMC7848023.
Kaske E, Pradela J, Otto M, John L, Derner N, Luedtke K. Factors affecting fear of attacks in patients with episodic migraine – a cross-sectional study. Cephalalgia Reports. 2025;8. doi:10.1177/25158163251345140.
Ossipova VV, Kolosova OA, Vein AM. Migraine associated with panic attacks. Cephalalgia. 1999 Oct;19(8):728-31. doi: 10.1046/j.1468-2982.1999.019008728.x. PMID: 10570728.
Raudenská J, Macko T, Vodičková Š, Buse DC, Javůrková A. Anxiety Disorders, Anxious Symptomology and Related Behaviors Associated With Migraine: A Narrative Review of Prevalence and Impact. Curr Pain Headache Rep. 2025 Jan 29;29(1):40. doi: 10.1007/s11916-024-01312-9. PMID: 39878907; PMCID: PMC11779792.
Smitherman TA, Kolivas ED, Bailey JR. Panic disorder and migraine: comorbidity, mechanisms, and clinical implications. Headache. 2013 Jan;53(1):23-45. doi: 10.1111/head.12004. Epub 2012 Dec 26. PMID: 23278473.
Stewart WF, Linet MS, Celentano DD. Migraine headaches and panic attacks. Psychosom Med. 1989 Sep-Oct;51(5):559-69. doi: 10.1097/00006842-198909000-00007. PMID: 2798702.
Suzuki K, Suzuki S, Haruyama Y, Funakoshi K, Fujita H, Sakuramoto H, Hamaguchi M, Kobashi G, Hirata K. Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Front Neurol. 2024 Feb 26;15:1373574. doi: 10.3389/fneur.2024.1373574. PMID: 38601337; PMCID: PMC11006273.
Takeshima T, Nakayama T, Sano H, Koga N, Matsukawa M. Association of Migraine Comorbidities with Quality of Life, Work Productivity and Daily Activities: Survey and Medical Claims Data in Japan. Adv Ther. 2025 Aug;42(8):3839-3860. doi: 10.1007/s12325-025-03236-1. Epub 2025 Jun 11. PMID: 40498280; PMCID: PMC12313757.
Yum J, Chu MK. Unraveling the connections between migraine and psychiatric comorbidities: A narrative review. Brain Dev. 2025 Aug;47(4):104392. doi: 10.1016/j.braindev.2025.104392. Epub 2025 Jul 8. PMID: 40633196.
close
EVEN MORE:
LATEST
ARTICLES
KEEPING UP
WITH THE SCIENCE
Shift work and headache: a new perspective
Summer, Sun, Headaches: Can heat really give you a headache?
Migraine & our sense of smell - more about an astonishing connection
Tension headaches: what causes them?
It’s all in your head? Yes – but the struggle is real!
Presenteeism: taking your headache to work
Uni without headaches – this is how it’s done
Migraine and evolution: why do the ‘migraine genes’ defy selection?
What came first? On sleeping problems and tension-type headache
When suffering increases: accompanying illnesses with headache
“Why am I so stressed?” – fighting headaches with resilience
MIGRAINE AND HEADACHE IN ADULTS – A GLOBAL CHALLENGE
QUIET, PLEASE – WHY SILENCE IS GOLDEN FOR THE BRAIN
Water = the best medicine for headache? Maybe not. But it’s pretty good.
Is it something I ate? Separating migraine fact from fiction
Give yourself a break – on university stress and headaches
Migraine and light: when brightness hurts
Digital detox – just another wellness fad?
Migraine on the beach: holiday headaches explained
Mental stress & headache in times of Covid
The winter blues increase your headache risk
Sloooow down. Stop your headache in its tracks